Authors

Gary Lerner, MD
Michelle A Thompson, MD
Crystal Phend<BR>Reviewed by Robert Jasmer, MD; Assistant Professor of Medicine, University of California, San Francisco
D. Brady Pregerson, MD
Charles J. Lockwood, MD, MHCM
STEVEN A. KING, MD, MS
GREGORY RUTECKI, MD
Anna D. Garrett, PharmD, BCPS
Christine Blank
Lisette Hilton
Salynn Boyles
Renee Dowling
Evan Brittain, MD, MSc
Patient Care Editorial Staff
Practical Cardiology Editorial Staff

Latest:

Screening for Cardiovascular Disease

Criteria and types of health care professionals who may screen patients at high risk for cardiovascular disease.

Endocrinology Network Editorial Staff
Nia Cason
Zackary D. Goff, MD
George Leef, MD
Faith Reidenbach
Gretchen Cuda Kroen
A. Shane Anderson, MD
Aaron Pumerantz, DO
Aaron Taylor Lee
Aisha T. Langford, PhD, MPH

Latest:

Baricitinib vs. Placebo or Adalimumab for Rheumatoid Arthritis

Compared to placebo and adalimumab, the addition of once-daily oral baricitinib produced significant clinical improvements in RA patients, research shows.

Alan P. Hudson, PhD
Alexei A. Grom, MD
Allison Tobola, MD
Alok Sachdeva, MD
Alok Vij, MD
<1
...
129130131132133134135136137
...
150>
© 2024 MJH Life Sciences

All rights reserved.